The recent studies have revealed anticancer and preventive effects of acetylshikonin, such as ROS-mediated caspase activation [40], induction of cell cycle arrest via p21 and caspase-3 activation [41], and suppression of the NF-κB activity [42] in various cancer cell lines. This evidence concerns the gene NFKB1 and cancer.